Jushi Holdings (JUSHF) Accumulated Expenses (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Accumulated Expenses came in at $27.0 million in Q1 2026, up 8.54% year-on-year from $24.9 million in Q1 2025, and up 5.91% on a QoQ basis from $25.5 million in Q4 2025.
Jushi Holdings (JUSHF) Accumulated Expenses (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Accumulated Expenses data on file, last reported at $27.0 million in Q1 2026.
- On a quarterly basis, Accumulated Expenses rose 8.54% year-over-year to $27.0 million in Q1 2026; TTM through Mar 2026 was $27.0 million, a 8.54% increase from a year earlier, with the FY2025 full-year figure at $25.5 million, down 22.13% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $27.0 million, up from $25.5 million in the prior quarter.
- Over the last five years, Accumulated Expenses for JUSHF reached as high as $49.9 million in Q2 2023 and fell as low as $24.9 million in Q1 2025.
- Historically, Accumulated Expenses has averaged $37.6 million across 5 years, with a median of $37.4 million in 2023.
- Across the five-year window, Accumulated Expenses advanced 10.67% in 2024 and plunged 42.27% in 2025, its largest moves.
- Year by year, Accumulated Expenses stood at $46.3 million in 2022, then fell by 4.88% to $44.1 million in 2023, then declined by 25.6% to $32.8 million in 2024, then slipped by 22.13% to $25.5 million in 2025, then increased by 5.91% to $27.0 million in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $27.0 million in Q1 2026, $25.5 million in Q4 2025, and $29.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.04 Mn |
| Dec 31, 2025 | 25.53 Mn |
| Sep 30, 2025 | 29.03 Mn |
| Jun 30, 2025 | 26.86 Mn |
| Mar 31, 2025 | 24.91 Mn |
| Dec 31, 2024 | 32.79 Mn |
| Sep 30, 2024 | 35.77 Mn |
| Jun 30, 2024 | 35.88 Mn |
| Mar 31, 2024 | 43.15 Mn |
| Dec 31, 2023 | 44.07 Mn |
| Sep 30, 2023 | 47.41 Mn |
| Jun 30, 2023 | 49.86 Mn |
| Mar 31, 2023 | 38.99 Mn |
| Dec 31, 2022 | 46.33 Mn |
| Sep 30, 2022 | 44.10 Mn |
| Jun 30, 2022 | 49.17 Mn |
| Dec 31, 2021 | 47.97 Mn |